<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04538573</url>
  </required_header>
  <id_info>
    <org_study_id>MOBILE</org_study_id>
    <nct_id>NCT04538573</nct_id>
  </id_info>
  <brief_title>Virtual Reality MObility for Burn Patients</brief_title>
  <acronym>VR-MOBILE</acronym>
  <official_title>Virtual Reality MObility for Burn Patients (VR-MOBILE): A Pilot Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Justine's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Justine's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Each year, more than 40 severely burned children aged 7 to 17 are treated at the&#xD;
      CHU Sainte-Justine trauma center. The treatment of burns, dressing changes as well as&#xD;
      physiotherapy, occupational therapy and hydrotherapy are considered to be among the most&#xD;
      painful medical procedures. These are usually recurrent treatments that generate a lot of&#xD;
      anxiety and can leave their long-term negative impact on the child's memory and relationship&#xD;
      to pain. To date, no distraction has been tried to distract these children during these&#xD;
      painful procedures. The use of virtual reality as a distraction tool has proven itself as a&#xD;
      non-pharmacological therapeutic modality. However, very little data exists on its use in this&#xD;
      context.&#xD;
&#xD;
      Hypothesis: VR distraction provides better pain relief during hydrotherapy, occupational&#xD;
      therapy and physiotherapy, in children from 7 to 17 years old.&#xD;
&#xD;
      Methods: Within-subject/crossover study design. Each child serves as his own control and&#xD;
      receives both standard and experimental treatment during the same treatment session through a&#xD;
      randomized order. Convenience sampling of 20 children aged from 6 to 17 years old presenting&#xD;
      with a burn injury to the medical-surgical unit or rehabilitation clinics of the CHU&#xD;
      Ste-Justine and CRME. Standard pharmacological care as per the unit's protocol will be given&#xD;
      to the control group as opposed to VR distraction combined with the Standard care for the&#xD;
      experimental group. Pain (NRS 0-10) and anxiety (CFS, 0-4) will be measured before the&#xD;
      treatment session at (T0), after the first sequence of the session (T1) and after the second&#xD;
      sequence of the session (T2) followed by a measure of parents' and healthcare professionals'&#xD;
      level of satisfaction via a questionnaire developed and pretested by the team. Memory of pain&#xD;
      and anxiety will be assessed about a week after the procedure (T3). Data is also collected on&#xD;
      the occurrence of side effects.&#xD;
&#xD;
      Discussion: The investigators believe that results of this study could transform a hospital&#xD;
      experience that is a priori negative, or even traumatic, into a fun and positive experience,&#xD;
      both for the children and the families by improving pain and anxiety management practices for&#xD;
      rehabilitation procedures for burn victims (hydrotherapy, physiotherapy, occupational&#xD;
      therapy) at a low cost.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND&#xD;
&#xD;
      Pediatric burn care procedures, in hydrotherapy, have been known to generate severe pain&#xD;
      intensity as well as moderate to high levels of anxiety. In the acute phase, burn patients&#xD;
      undergo several painful procedures such as wound debridement, passive range-of-motion (ROM)&#xD;
      exercises and dressing changes treatments. These procedures are important for proper&#xD;
      rehabilitation as they prevent contractures, muscle spasms and limited joint mobility, which&#xD;
      are mainly related to scarring and loss of skin elasticity as secondary complications&#xD;
      resulting with normal healing process following a burn injury.&#xD;
&#xD;
      Hydrotherapy treatments for burn care are done with the use of opioids and benzodiazepines&#xD;
      for their pain and anxiety, strong medications alone are often inadequate to control their&#xD;
      pain and anxiety. Since those treatments cause a great deal of pain, high dosage is needed in&#xD;
      order to reach an acceptable relief with the medication. The delicate balance between pain&#xD;
      relief and the dosage used is often at the limit of respiratory depression. Unfortunately,&#xD;
      non-pharmacological methods are rarely combined with the pharmacological treatments used to&#xD;
      relieve pain during those procedures even if they could decrease the necessary dose of&#xD;
      analgesics.&#xD;
&#xD;
      Virtual Reality (VR) is a distraction method that allows the user to interact with an&#xD;
      immersive environment generated by a computer stimulating different senses. The use of VR is&#xD;
      promising for pain reduction in varying settings. Other positive effects including reduction&#xD;
      of anxiety and general distress during different painful medical procedures (such as&#xD;
      venipuncture, wound care, chemotherapy and dental procedures) have been reported by children&#xD;
      and adults. Further, recent randomized-controlled trials, comparing VR and standard&#xD;
      distraction in children undergoing blood drawn procedures, demonstrated a significant&#xD;
      positive effect of VR on reduction of pain and anxiety and enhanced patients', caregivers'&#xD;
      and phlebotomist's satisfaction. Also, Gold and Maher concluded that VR was more effective&#xD;
      for children with higher anxiety sensitivity, adding another gain for the adoption of this&#xD;
      new technology in children's health care.&#xD;
&#xD;
      Only a few authors have studied the effect of Virtual Reality (VR) on procedural pain and&#xD;
      anxiety management in burn children older than 6 years. Indeed, a review of the literature&#xD;
      has yielded only three studies who used VR with burn children. Schmitt et al., compared the&#xD;
      efficacy of VR with standard pharmacological care in an RCT on 54 children (6 to 19 years)&#xD;
      suffering from burn-related injuries with TBSA (Total Body Surface Area) varying from 1 to&#xD;
      50. Results showed better pain control and maximum ROM in children in the VR group. Another&#xD;
      study combined participants from three studies (to increase power) to compare the use of VR&#xD;
      with standard pharmacological care with children undergoing physical therapy following a&#xD;
      major burn. Results on 110 children also showed that VR significantly decreased pain and&#xD;
      unpleasantness related to pain in children with burns.&#xD;
&#xD;
      Furthermore, Virtual Reality has shown positive effects with burn children who underwent&#xD;
      hydrotherapy sessions and dressing changes. Although, very few studies have looked at the&#xD;
      effect of VR on the management of pain, anxiety and memory of both in children undergoing&#xD;
      painful burn wound care. Distractions are an interesting non-pharmacological method that can&#xD;
      be used. We believe that Virtual Reality (VR) as an adjunct to current burn care (standard&#xD;
      pharmacological treatment), could be easily adopted by hydrotherapy staff as part of their&#xD;
      care as it is an easy to use and low-cost intervention. Also, we believe that it could help&#xD;
      make the overall recovery process less painful and less distressful for burn children.&#xD;
&#xD;
      Also, there is evidence to suggest that reducing procedural pain and distress in the&#xD;
      short-term, will have long lasting effects on children's pain and health trajectories in the&#xD;
      long-term. The effect of pain on a developing child does not end after painful procedures&#xD;
      end; how children remember these experiences can have long lasting effects. Children who&#xD;
      recall pain in negatively-biased ways (i.e., they recall more pain than an earlier pain&#xD;
      report) experience more pain and distress at future pain experiences and are at risk for&#xD;
      developing persistent pain problems and fears and avoidance of medical care . Importantly,&#xD;
      children (and parents) who are more anxious and distressed prior to painful medical&#xD;
      procedures, and who experience higher pain during medical procedures, are the very children&#xD;
      who develop these negatively biased recalls. Additionally, one study of youth undergoing&#xD;
      vaccine injections showed that interventions to reduce pain and distress (distraction,&#xD;
      topical anesthetic) buffered against the development of negatively biased recalls. Therefore,&#xD;
      we will also examine the effect of VR distraction, a more immersive intervention, on&#xD;
      children's later recall of pain. This is innovative as we did not find any other studies&#xD;
      using VR and collecting data on pain and anxiety recalls in children following painful&#xD;
      medical procedures. Further, we will compare salivary Alpha-Amylase levels between groups,&#xD;
      which is a reliable and valid surrogate marker of stress that increases in response to&#xD;
      physical and psychological stressful conditions such as experience of medical procedures. It&#xD;
      is also more sensitive and rises more quickly after a painful procedure (10 min) than&#xD;
      cortisol (35-40 min).&#xD;
&#xD;
      Finally, considering the lack of optimal pain and anxiety management during burn wound care&#xD;
      and the positive effect of an immersive distraction method such as VR for painful procedures,&#xD;
      using VR for burn wound care procedures may show promising results. To our knowledge, no&#xD;
      other studies have tested the effect of an immersive distraction such as VR for procedural&#xD;
      pain management in children undergoing these painful orthopedic procedures.&#xD;
&#xD;
      AIM&#xD;
&#xD;
      The aim of this within-subject randomized clinical trial is to examine the efficacy of an&#xD;
      immersive distraction (virtual reality) compared to the standard treatment for pain and&#xD;
      anxiety management in children requiring burn wound car in hydrotherapy sessions.&#xD;
&#xD;
      HYPOTHESIS&#xD;
&#xD;
      The use of Virtual Reality (VR) as an adjunct intervention to current burn care (standard&#xD;
      pharmacological treatment) will provide better pain and anxiety management than standard&#xD;
      pharmacological treatment alone.&#xD;
&#xD;
      OBJECTIVES:&#xD;
&#xD;
        1. To determine if VR distraction combined with analgesics is more effective than standard&#xD;
           treatment (analgesics alone) to manage procedural pain of children with burn injuries&#xD;
           during hydrotherapy sessions.&#xD;
&#xD;
        2. To compare if VR distraction combined with analgesics is more effective than standard&#xD;
           pharmacological treatment to manage procedural anxiety of children with burn injuries&#xD;
           during hydrotherapy sessions.&#xD;
&#xD;
        3. To compare if, in children with burn injuries, VR distraction combined with the standard&#xD;
           pharmacological treatment sequence generate less distressing recall of procedural pain&#xD;
           and anxiety than standard pharmacological treatment alone sequence.&#xD;
&#xD;
        4. To compare the occurrence of side effects between VR distraction combined with the&#xD;
           standard pharmacological treatment sequence and standard pharmacological treatment alone&#xD;
           sequence.&#xD;
&#xD;
        5. To compare healthcare professionals' satisfaction levels between VR distraction combined&#xD;
           with pharmacological treatment sequence and standard pharmacological treatment alone&#xD;
           sequence.&#xD;
&#xD;
        6. To compare children's satisfaction levels between VR distraction combined with standard&#xD;
           pharmacological treatment sequence and standard pharmacological treatment alone sequence&#xD;
           alone.&#xD;
&#xD;
      METHODS&#xD;
&#xD;
      Design: A within-subject randomized clinical trial design with randomized sequences. Given&#xD;
      the difficulty of ensuring any blinding conditions with the nature of the experimentation,&#xD;
      and in order to limit the interpersonal variability between participants, each child will&#xD;
      serve as their own control, hence receiving both standard (control) and experimental&#xD;
      treatments (VR) during the same treatment session through a randomized order.&#xD;
&#xD;
      Sample and Settings: Recruitment will be done through convenience sampling upon admission to&#xD;
      the surgical-trauma burn unit at CHU Ste-Justine, Montreal (Qc), Canada. Originally, this&#xD;
      study also included a followup with those same patients at the rehabilitation clinic for&#xD;
      physiotherapy. Unfortunately, due to the COVID sanitary crisis, recruiting personnel&#xD;
      availability and the difficulty of movement between units and to clinics, recruiting will be&#xD;
      limited to the burn unit. Using a within-subject design allows the possibility of recruiting&#xD;
      a minimum of 20 participants in order to have effectively 40 patients since they will act as&#xD;
      their own control.&#xD;
&#xD;
      Measures and outcomes: Timepoints. Data will be collected by research assistants/nurses at&#xD;
      the following study times: before the procedure to establish baseline (T0), immediately after&#xD;
      the first sequence (T1), immediately after the second sequence (T2) and one week after the&#xD;
      procedure (T3).&#xD;
&#xD;
      Sample Size: Since this is a pilot study there is usually no specific requirements regarding&#xD;
      the sample size. However, it is recommended by some authors to use about a total of 20&#xD;
      patients (overall, 40 patients since all patients will serve as their own control) to be able&#xD;
      to proceed to statistical analyses required for this study.&#xD;
&#xD;
      Data analysis plan: Comparisons will be conducted within and between subjects for the&#xD;
      dependent variables for repeated measures. The mean difference in pain scores of patients at&#xD;
      each time-period will be compared using a paired t-test or Wilcoxon sign-rank test. Since the&#xD;
      use of rescue medication is a potential indication of a treatment failure, the primary&#xD;
      analysis will be supplemented by an analysis comparing the proportion of patients receiving&#xD;
      rescue medication anytime during the procedure. Interpretation of the primary analyses will&#xD;
      be made with reference to the data regarding rescue medication use. Data collected on&#xD;
      dichotomous variables will be analyzed using a chi-square test and post-hoc analyses if the&#xD;
      results are statistically significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 9, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Every patient (20) will be their own control (20+20 = 40). Allocation to either intervention or control will be randomized at first and then switched at the crossover period.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity: Numerical Rating Scale (NRS)</measure>
    <time_frame>Before the procedure to establish baseline (T0); immediately after the first sequence (T1); immediately after the second sequence (T2)</time_frame>
    <description>Assessed using the Numerical Rating Scale (NRS). The NRS is an 11-item scale for pain intensity ranging from 0 to 10; 0=no pain to 10= worst pain ever felt.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Levels of anxiety</measure>
    <time_frame>Before the procedure to establish baseline (T0); immediately after the first sequence (T1); immediately after the second sequence (T2)</time_frame>
    <description>Assessed using the Child Fear Scale (CFS). The CFS is a self-reported measure of anxiety adapted from the Faces Anxiety Scale for specific use in children undergoing painful experiences. It consists of five faces ranging from 0 (no fear/anxiety) through 4 (extremely fearful/anxious). The child is asked to indicate which face shows best how he/she felt during the procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean difference in cognitive, affective and sensory components of pain between groups</measure>
    <time_frame>Immediately after the first sequence (T1); immediately after the second sequence (T2)</time_frame>
    <description>Assessed using the Graphic Rating Scale (GRS), a 7-item Likert-type scale tailored for virtual reality interventions ranging from 0 to 10, where 0 is indicating &quot;none&quot; and 10; &quot;great amount&quot; depending on what de scale is measuring (pain, how unpleasant the experience was, etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parent's and children's satisfaction levels</measure>
    <time_frame>Immediately after the second sequence (T2)</time_frame>
    <description>Assessed using a 0 (not satisfied) to 10 (extremely satisfied) numerical scale to answer the following question as recommended by PedIMMPACT: &quot;Considering pain relief, side effects, physical recovery, and emotional recovery, how satisfied were you with the treatments you/your child received for pain?&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healthcare professional's satisfaction level</measure>
    <time_frame>Immediately after the second sequence (T2)</time_frame>
    <description>Assessed using a tailored questionnaire with four-choices response scale from &quot;Strongly agree&quot; to &quot;Strongly disagree&quot; for 7 items related to their level of satisfaction with the intervention and its effect on the procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for rescue medication</measure>
    <time_frame>Immediately after the first sequence (T1); immediately after the second sequence (T2)</time_frame>
    <description>Recorded as a clinical data.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of adverse events</measure>
    <time_frame>Immediately after the first sequence (T1); immediately after the second sequence (T2)</time_frame>
    <description>Assessed and documented from enrolment until discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean differences in children's memory of pain</measure>
    <time_frame>One week after the procedure (T3)</time_frame>
    <description>Assessed using the same scale administered during the initial session: Numerical Rating Scale (NRS) but framed in terms of recall. It is an 11-item scale for pain intensity ranging from 0 to 10; 0=no pain to 10= worst pain ever felt.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean differences in children's memory of anxiety</measure>
    <time_frame>One week after the procedure (T3)</time_frame>
    <description>Assessed using the same scale administered during the initial session: Child Fear Scale (CFS) but framed in terms of recall. It is a self-reported measure of anxiety adapted from the Faces Anxiety Scale for specific use in children undergoing painful experiences. It consists of five faces ranging from 0 (no fear/anxiety) through 4 (extremely fearful/anxious).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean differences in maximal range-of-motion of injured limb(s)</measure>
    <time_frame>Immediately after the first sequence (T1); immediately after the second sequence (T2)</time_frame>
    <description>Assessed by the physical therapist using a goniometer.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pediatric Burns</condition>
  <arm_group>
    <arm_group_label>Virtual Reality Distraction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of virtual reality (VR) during during burn treatment, dressing changes and hydrotherapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard treatment during burn treatment, dressing changes and hydrotherapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Virtual Reality Distraction</intervention_name>
    <description>Patients in this group will be offered to use Oculus Rift goggles while undergoing the burn treatments, dressing changes and hydrotherapy to reduce pain and anxiety during treatment. The goggles will display Dreamland, a virtual reality videogame created by our team to maximize fun, diminish difficulty, and motion sickness. The system will be available 5 minutes before treatment to the patient in order to ease acclimatation to the goggles until the end of the treatment session.</description>
    <arm_group_label>Virtual Reality Distraction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard Treatment</intervention_name>
    <description>During this sequence, patients with standard care will only be offered standard pharmacological treatment. Use of any co-interventions for pain or anxiety management (music, comforting, child life specialist or other) during this sequence will be documented.</description>
    <arm_group_label>Standard Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Between the ages of 6 to 17 years and suffering from a burn injury requiring&#xD;
             hydrotherapy, physiotherapy or occupational therapy care&#xD;
&#xD;
          -  Presence of a consenting parent who can understand, read and write either French or&#xD;
             English.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have a diagnosed cognitive impairment precluding them from playing a virtual reality&#xD;
             game&#xD;
&#xD;
          -  Suffer from epilepsy considering the nature of the intervention&#xD;
&#xD;
          -  Have burn injuries on the face preventing the use of the Oculus Quest Helmet&#xD;
&#xD;
          -  Cannot be in a sitting or semi-upright sitting position (semi-Fowler's position)&#xD;
             during the procedure as the virtual reality game requires an angle of at least 30&#xD;
             degrees for head-tracking. Participants who received analgesics (e.g. acetaminophen,&#xD;
             ibuprofen) or anxiolytics (e.g. benzodiazepines) during the last 4 hours prior to the&#xD;
             procedure will not be excluded but the name of medication, dosage and time of&#xD;
             administration will be documented in the data collection form.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sylvie Le May, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Justine's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sylvie Le May, PhD</last_name>
    <phone>514-345-4931</phone>
    <phone_ext>4938</phone_ext>
    <email>sylvie.lemay@umontreal.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Justine's Hospital</name>
      <address>
        <city>Montr√©al</city>
        <state>Quebec</state>
        <zip>H1T 3C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Sylvie Le May, PhD</last_name>
      <phone>514-345-4931</phone>
      <phone_ext>4938</phone_ext>
      <email>sylvie.lemay@umontreal.ca</email>
    </contact>
    <investigator>
      <last_name>Sylvie Le May, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 30, 2020</study_first_submitted>
  <study_first_submitted_qc>September 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 4, 2020</study_first_posted>
  <last_update_submitted>June 28, 2021</last_update_submitted>
  <last_update_submitted_qc>June 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Justine's Hospital</investigator_affiliation>
    <investigator_full_name>Sylvie Le May</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

